Cardiovascular ultrasound is the most commonly used noninvasive diagnostic imaging method for real time assessment of heart structure, function, and hemodynamics. Because of its availability, diagnostic advantages, and relatively low cost, echocardiography is rapidly becoming the imaging technique of choice in clinical research. Cardiovascular ultrasound can be readily incorporated into a clinical trial as a marker of cardiac safety and as a measurement of the therapeutic effects of drugs and devices being evaluated for regulatory approval.
Nonetheless, the quality of data collected can make the difference between the success and failure of a clinical research trial. When designing and implementing a clinical trial or cardiac safety study, special consideration must be taken to coordinate and standardize the ultrasound imaging protocol and provide adequate site training to ensure high image quality and minimize data variability.
Built on a strong foundation of collective knowledge and experience in cardiovascular research and development, CUORE International offers expert consulting and services to our clinical research partners specifically designed to directly support their investigative efforts and continuous quality improvement (CQI) initiatives. Whether you are an investigator, sponsor, CRO, or clinical site involved in the development of a new pharmacological agent or medical device, CUORE International can help you confidently achieve your goals by offering customizable solutions to meet your needs and expectations.
Some of our offerings designed to support cardiovascular ultrasound trials include:
Cardiovascular ultrasound protocol development for clinical trials